Awarded
Suministro del principio activo denominado PERTUZUMAB/TRASTUZUMAB VIAL SUBCUTÁNEO (PHESGO), para el Servicio de Farmacia delComplejo Hospitalario Universitario de Canarias.
Track this recordFree account — get alerted when a contract here runs out.
- Winners
- ROCHE FARMA SA
- Contract value
- €1,405,590
- Bids received
- 1
- Published
- 24 Mar 2025
- Awarded
- 19 Mar 2025
- Contract start
- 19 Mar 2025
- Contract end
- 20 Mar 2026estimated